statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	940
SG - Singapore	249
CN - Cina	141
DE - Germania	64
BR - Brasile	56
VN - Vietnam	54
HK - Hong Kong	39
IT - Italia	39
UA - Ucraina	37
GB - Regno Unito	34
TR - Turchia	22
FI - Finlandia	18
FR - Francia	17
CA - Canada	14
MX - Messico	14
SE - Svezia	14
IN - India	11
JP - Giappone	11
RU - Federazione Russa	9
BD - Bangladesh	8
AR - Argentina	7
BE - Belgio	6
ES - Italia	5
ZA - Sudafrica	4
IR - Iran	3
PK - Pakistan	3
PL - Polonia	3
AZ - Azerbaigian	2
CO - Colombia	2
EC - Ecuador	2
JO - Giordania	2
PA - Panama	2
PH - Filippine	2
SA - Arabia Saudita	2
SI - Slovenia	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AO - Angola	1
AT - Austria	1
BW - Botswana	1
CH - Svizzera	1
CL - Cile	1
CZ - Repubblica Ceca	1
EG - Egitto	1
HN - Honduras	1
ID - Indonesia	1
IE - Irlanda	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
KW - Kuwait	1
LB - Libano	1
LT - Lituania	1
MT - Malta	1
MU - Mauritius	1
MY - Malesia	1
NP - Nepal	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.867

Nome	#
A non-invasive method for the in vivo determination of skin antioxidant capacity	299
Novel selective human mitochondrial kinase inhibitors: Design, synthesis and enzymatic activity	226
Hindered nucleoside analogs as antiflaviviridae agents	202
Design, Synthesis and Anti Flaviviridae Activity of N 6-, 5,3-O- and 5,2-O-Substituted Adenine Nucleoside Analogs	196
Design, synthesis and binding at cloned muscarinic receptors of N-[5-(1'-substituted-acetoxymethyl)-3-oxadiazolyl] and N-[4-(1'-substituted-acetoxymethyl)-2-dioxolanyl] dialkyl amines	184
Design, Synthesis and activity of a new series of nucleoside analogues displaying potent antiflaviviridae activity.	165
Determinazione dell'efficacia antiossidante di formulazioni cosmetiche attraverso metodiche non invasive	152
Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase	114
The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes	93
null	88
Ribonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates	87
Synthesis, modeling and evaluation of 3'-(1-aryl-1H-tetrazol-5-ylamino)-substituted 3'-deoxythymidine derivatives as potent and selective human mitochondrial thymidine kinase inhibitors	70
Totale	1.876

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	28	0	0	0	0	0	0	0	0	0	8	16	4
2021/2022	101	2	3	15	5	6	4	6	1	4	7	10	38
2022/2023	113	9	6	4	17	23	19	10	4	14	0	6	1
2023/2024	55	7	11	5	0	7	6	0	2	6	0	1	10
2024/2025	320	7	8	24	24	38	58	16	10	30	21	49	35
2025/2026	763	80	22	46	136	165	66	85	31	77	55	0	0
Totale													1.876

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara